Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation

JAMA Intern Med. 2015 Jul;175(7):1244-5. doi: 10.1001/jamainternmed.2015.1286.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Antithrombins / adverse effects*
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects*
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Male
  • Warfarin / adverse effects*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Antithrombins
  • Benzimidazoles
  • beta-Alanine
  • Warfarin